Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2010
08/18/2010EP2218464A1 Compounds for non-invasive measurement of aggregates of amyloid peptides
08/18/2010EP2218330A1 Process for the preparation of 2-ethyl-4,6-dimethylphenyl acetic acid by reacting 2-ethyl-4,6-dimethylbromobenzene with tert.-butylacetate
08/18/2010EP2217604A1 Gamma secretase modulators
08/18/2010EP2217603A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2
08/18/2010EP2217601A1 Imidazopyridazines for use as protein kinase inhibitors
08/18/2010EP2217600A2 Fungicidal bicyclic pyrazoles
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP2217239A2 Modulation of protein trafficking
08/18/2010EP1940828B1 Heterocyclic aspartyl protease inhibitors
08/18/2010EP1858896B1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010EP1709049B1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
08/18/2010CN1922182B Pyrrolotriazine compounds as kinase inhibitors
08/18/2010CN101809021A octahydro-pyrrolo[3,4-b]pyrrole n-oxides
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101809014A Method for producing pyrazol-3-yl-benzamide derivative
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101805342A Method for recycling urotropine and glycine in glycine-methanol mother liquor
08/18/2010CN101805341A inhibitors of bruton's tyrosine kinase
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101367819B 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof
08/18/2010CN101225086B Method for synthesizing mu-oxo binuclear ferriporphyrin
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7777033 Durable antimicrobial activity and heat resistance, non-eluting to prevent toxicity, and do not adversly effect properties of molded products; use in packaging, appliances, cosmetics, and medical equipment; e.g. polymerizable derivatives of grepafloxacin
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7777028 Preparation of metal mesoporphyrin compounds
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776865 checkpoint kinase inhibitors; for treating and preventing proliferative diseases such as cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
08/17/2010US7776864 Fused bicyclic pyrimidines
08/17/2010US7776852 Process for producing highly pure midazolam and salts thereof
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010US7776568 Methods and kits using extended rhodamine dyes
08/17/2010CA2551867C Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
08/17/2010CA2427227C Lactam compound
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/12/2010WO2010091386A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010WO2010091310A1 Inhibitors of jun n-terminal kinase
08/12/2010WO2010091176A1 Phthalazine-containing antidiabetic compounds
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010091067A2 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
08/12/2010WO2010090764A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2010090319A1 Coelenterazine analogs and manufacturing method thereof
08/12/2010WO2010090178A1 Donor-acceptor compound
08/12/2010WO2010089943A1 Printing ink or toner containing dihydroperimidine squarylium compound, printed matter, method for detection of information, and method for ascertaining the genuineness of articles or substrates
08/12/2010WO2010089509A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089508A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089507A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089506A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089292A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010089084A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010US20100204470 method for salt preparation
08/12/2010US20100204465 Refined routes to chlorin building blocks
08/12/2010US20100204438 Method for producing teda derivatives
08/12/2010US20100204239 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/12/2010US20100204237 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
08/12/2010US20100204235 Organic compounds
08/12/2010US20100204230 Piperazine derivatives for treatment of ad and related conditions
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204221 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/12/2010US20100204197 Pyrrolopyrimidines
08/12/2010US20100204196 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
08/12/2010US20100203113 Wnt signalling inhibitors, and methods for making and using them
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010US20100200066 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
08/12/2010CA2751539A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751535A1 Substituted spiro-amides as b1r modulators
08/12/2010CA2751525A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2751474A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as metinhibitors
08/12/2010CA2751458A1 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2751141A1 Inhibitors of jun n-terminal kinase
08/12/2010CA2750935A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010CA2750875A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010CA2750517A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
08/12/2010CA2748943A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010CA2748862A1 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
08/11/2010EP2216411A1 Process for production of pyrrole compound
08/11/2010EP2215094A1 N-containing heterocyclic compounds
08/11/2010EP2214669A1 Cytokine inhibitors
08/11/2010EP1937688B1 Imidazo benzodiazepine derivatives
08/11/2010EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3
08/11/2010CN101801975A Pyrazolo-pyrazines derivatives used as g protein inhibitors
08/11/2010CN101801974A Process for the manufacture of bridged monobactam intermediates
08/11/2010CN101801973A Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
08/11/2010CN101801972A Pyrazolo [1,5-A]pyrimidines as inhibitors of stearoyl-coA desaturase
08/11/2010CN101801971A Deazapurines useful as inhibitors of janus kinases
08/11/2010CN101801969A Indolyl pyrrolidines for the treatment of cancer
08/11/2010CN101801966A Bicyclic heteroaryl compounds and their use as kinase inhibitors
08/11/2010CN101801958A Heterocyclic amide compounds as protein kinase inhibitors
08/11/2010CN101801954A Compounds and compositions as modulators of GPR119 activity
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 573